Nanodiamond-mediated delivery of water-insoluble therapeutics

ACS Nano

Volumn 3, Issue 7, 2009, Pages 2016-2022

  Chen, Mark ^a   Pierstorff, Erik D ^b   Lam, Robert ^b   Li, Shu You ^a   Huang, Houjin ^b   Osawa, Eiji ^c   Ho, Dean ^b,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c SHINSHU UNIVERSITY   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Chemotherapy; Liver cancer; Nanodiamond; Nanomedicine

Indexed keywords

ANTI-INFLAMMATORIES; BRAIN CANCER; BREAST CANCER; DEXAMETHASONES; FUNCTIONALIZATIONS; HEPATOCARCINOMA; INSOLUBLE COMPOUNDS; LIVER CANCER; LIVER CANCERS; MEDIATED INTERACTION; NANODIAMOND; NANOMEDICINE; PLATFORM APPROACH; WATER DISPERSIBLE;

CHEMOTHERAPY; DIAMONDS; LIGANDS; LIVER; MEDICAL NANOTECHNOLOGY;

WATER RECYCLING;

EID: 68649118426     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn900480m     Document Type: Article

References (45)

1. Goga, A.; Yang, D.; Tward, A. D.; Morgan, D. O.; Bishop, J. M. Inhibition of Cdk1 as a Potential Therapy for Tumors Over-Expressing myc. Nat. Med. 2007, 13, 820-827.
2. Pantazis, P. Preclinical Studies of Water-Insoluble Camptothecin Congeners: Cytotoxicity, Development of Resistance, and Combination Treatments. Clin. Cancer Res. 1995, 1, 1235-1244.
3. Villerbu, N.; Gaben, A. M.; Redeuilh, G.; Mester, J. Cellular Effects of Purvalanol A: A Specific Inhibitor of Cyclin- Dependent Kinase Activities. Int. J. Cancer 2002, 97, 761-769.
4. May, F. E.; Westley, B. R. Effects of Tamoxifen and 4- Hydroxytamoxifen on the PNR-1 and PNR-2 Estrogen- Regulated RNAs in Human Breast Cancer Cells. J. Biol. Chem. 1987, 262, 15894-15899.
5. Rouanet, P.; Linares-Cruz, G.; Dravet, F.; Poujol, S.; Gourgou, S.; Simony-Lafontaine, J.; Grenier, J.; Kramar, A.; Girault, J.; Le Nestour, E.; et al. Neoadjuvant Percutaneous 4-Hydroxytamoxifen Decreases Breast Tumoral Cell Proliferation: A Prospective Controlled Randomized Study Comparing Three Doses of 4-Hydroxytamoxifen Gel to Oral Tamoxifen. J. Clin. Oncol. 2005, 23, 2980-2987.
6. Kim, Y.; Dalhaimer, P.; Christian, D. A.; Discher, D. Polymeric Worm Micelles as Nano-Carriers for Drug Delivery. Nanotechnology 2005, 16, S484-S491.
7. Zhang, L.; Chan, J. M.; Gu, F. X.; Rhee, J.-W.; Wang, A. Z.; Radovic-Moreno, A. F.; Alexis, F.; Langer, R. S.; Farokhzad, O. C. Self-Assembled Lipid-Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform. ACS Nano 2008, 2, 1696-1702.
8. Zhang, L.; Radovic-Moreno, A. F.; Alexis, F.; Gu, F. X.; Basto, P. A.; Bagalkot, V.; Sangyong, J.; Langer, R. S.; Farokhzad, O. C. Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates. ChemMedChem 2007, 2, 1268-1271.
9. Sheihet, L.; Dubin, R. A.; Devore, D.; Kohn, J. Hydrophobic Drug Delivery by Self-Assembling Triblock Copolymer- Derived Nanospheres. Biomacromolecules 2005, 6, 2726-2731.
10. Deming, T. J. Methodologies for Preparation of Synthetic Block Copolypeptides: Materials with Future Promise in Drug Delivery. Adv. Drug Delivery Rev. 2002, 54, 1145-1155.
11. Lacerda, L.; Bianco, A.; Prato, M.; Kostarelos, K. Carbon Nanotubes as Nanomedicines: From Toxicology to Pharmacology. Adv. Drug Delivery Rev. 2006, 58, 1460-1470.
12. Langer, R. New Methods of Drug Delivery. Science 1990, 249, 1527-1533.
13. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat. Nanotechnol. 2007, 2, 751-760.
14. Kam, N. W. S.; O'Connell, M.; Wisdom, J. A.; Dai, H. Carbon Nanotubes as Multifunctional Biological Transporters and Near-Infrared Agents for Selective Cancer Cell Destruction. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 11600-11605.
15. Liu, Z.; Robinson, J. T.; Sun, X.; Dai, H. PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer Drugs. J. Am. Chem. Soc. 2008, 130, 10876-10877.
16. Gruen, D. M. Nanocrystalline Diamond Films. Annu. Rev. Mater. Sci. 1999, 29, 211-259.
17. Arenal, R.; Bruno, P.; Miller, D. J.; Lal, J.; Bleul, M.; Gruen, D. M. Diamond Nanowires and the Insulator-Metal Transition in Ultrananocrystalline Diamond Films. Phys. Rev. B 2007, 75, 195431.
18. Yeap, W. S.; Tan, Y. Y.; Loh, K. P. Using Detonation Nanodiamond for the Specific Capture of Glycoproteins. Anal. Chem. 2008, 80, 4659-4665.
19. Krüger, A. Hard and Soft: Biofunctionalized Diamond. Angew. Chem., Int. Ed. 2006, 45, 6426-6427.
20. Huang, L.-C. L.; Chang, H.-C. Adsorption and Immobilization of Cytochrome c on Nanodiamonds. Langmuir 2004, 20, 5879-5884.
21. Mochalin, V.; Gogotsi, Y. Wet Chemistry Route to Hydrophobic Blue Fluorescent Nanodiamond. J. Am. Chem. Soc. 2009, 131, 4594-4595.
22. Krüger, A.; Kataoka, F.; Ozawa, M.; Fujino, T.; Suzuki, Y.; Aleksenskii, A. E.; Vul, A. Y.; Ōsawa, E. Unusually Tight Aggregation in Detonation Nanodiamond: Identification and Disintegration. Carbon 2005, 43, 1722-1730.
23. Bondar, V. S.; Puzyr, A. P. Nanodiamonds for Biological Investigations. Phys. Solid State 2004, 46, 716-719.
24. Ozawa, M.; Inaguma, M.; Takahashi, M.; Kataoka, F.; Krüger, A.; Ō sawa, E. Preparation and Behavior of Brownish, Clear Nanodiamond Colloids. Adv. Mater. 2007, 19, 1201-1206.
25. Kossovsky, N.; Gelman, A.; Hnatyszyn, H. J.; Rajguru, S.; Garrell, R. L.; Torbati, S.; Freitas, S. S. F.; Chow, G.-M. Surface-Modified Diamond Nanoparticles as Antigen Delivery Vehicles. Bioconjugate Chem. 1995, 6, 507-511.
26. Huang, H.; Pierstorff, E.; Ōsawa, E.; Ho, D. Active Nanodiamond Hydrogels for Chemotherapeutic Delivery. Nano Lett. 2007, 7, 3305-3314.
27. Huang, H.; Pierstorff, E.; Ōsawa, E.; Ho, D. Protein-Mediated Assembly of Nanodiamond Hydrogels into a Biocompatible and Biofunctional Multilayer Nanofilm. ACS Nano 2008, 2, 203-212.
28. Lam, R.; Chen, M.; Pierstorff, E.; Huang, H.; Osawa, E.; Ho, D. Nanodiamond-Embedded Microfilm Devices for Localized Chemotherapeutic Elution. ACS Nano 2008, 2, 2095-2102.
29. Huang, H.; Chen, M.; Bruno, P.; Lam, R.; Robinson, E.; Gruen, D.; Ho, D. Ultrananocrystalline Diamond Thin Films Functionalized with Therapeutically Active Collagen Networks. J. Phys. Chem. B 2009, 113, 2966-2971.
30. Dolmatov, V. Y. Detonation Synthesis Ultradispersed Diamonds: Properties and Applications. Russ. Chem. Rev. 2001, 70, 607-626.
31. Schrand, A. M.; Huang, H.; Carlson, C.; Schlager, J. J.; Ōsawa, E.; Hussain, S. M.; Dai, L. Are Diamond Nanoparticles Cytotoxic? J. Phys. Chem. B 2007, 111, 2-7.
32. Liu, K.-K.; Cheng, C.-L.; Chang, C.-C.; Chao, J.-I. Biocompatible and Detectable Carboxylated Nanodiamond on Human Cell. Nanotechnology 2007, 18, 325102.
33. Yu, S.-J.; Kang, M.-W.; Chang, H.-C.; Chen, K.-M.; Yu, Y.-C. Bright Fluorescent Nanodiamonds: No Photobleaching and Low Cytotoxicity. J. Am. Chem. Soc. 2005, 127, 17604-17605.
34. Härtl, A.; Schmich, E.; Garrido, J. A.; Hernando, J.; Catharino, S. C. R.; Walter, S.; Feulner, P.; Kromka, A.; Steinmüller, D.; Stutzmann, M. Protein-Modified Nanocrystalline Diamond Thin Films for Biosensor Applications. Nat. Mater. 2004, 3, 736-742.
35. Yang, W.; Auciello, O.; Butler, J. E.; Cai, W.; Carlisle, J. A.; Gerbi, J. E.; Gruen, D. M.; Knickerbocker, T.; Lasseter, T. L.; Russell, J. N. DNA-Modified Nanocrystalline Diamond Thin- Films as Stable, Biologically Active Substrates. Nat. Mater. 2002, 1, 253-257.
36. Neugart, F.; Zappe, A.; Jelezko, F.; Tietz, C.; Boudou, J. P.; Krueger, A.; Wrachtrup, J. Dynamics of Diamond Nanoparticles in Solution and Cells. Nano Lett. 2007, 7, 3588-3591.
37. Fisher, B.; Costantino, J. P.; Wickerham, D. L.; Redmond, C. K.; Kavanah, M.; Cronin, W. M.; Vogel, V.; Robidoux, A.; Dimitrov, N.; Atkins, J.; et al. Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 1998, 90, 1371-1388.
38. Fisher, B.; Dignam, J.; Wolmark, N.; Wickerham, D. L.; Fisher, E. R.; Mamounas, E.; Smith, R.; Begovic, M.; Dimitrov, N. V.; Margolese, R. G.; et al. Tamoxifen in Treatment of Intraductal Breast Cancer: National Surgical Adjuvant Breast and Bowel Project B-24 Randomised Controlled Trial. Lancet 1999, 353, 1993-2000. (Pubitemid 29271743)
39. Taylor, C. M.; Blanchard, B.; Zava, D. T. Estrogen Receptor- Mediated and Cytotoxic Effects of the Antiestrogens Tamoxifen and 4-Hydroxytamoxifen. Cancer Res. 1984, 44, 1409-1414.
40. Kip1, and Modulation of Bcl-2 Family Members. Clin. Cancer Res. 2005, 11, 2345-2354.
41. Kircheis, R.; Wightman, L.; Wagner, E. Design and Gene Delivery Activity of Modified Polyethylenimines. Adv. Drug Delivery Rev. 2001, 53, 341-358.
42. Bettinger, T.; Remy, J.-S.; Erbacher, P. Size Reduction of Galactosylated PEI/DNA Complexes Improves Lectin- Mediated Gene Transfer into Hepatocytes. Bioconjugate Chem. 1999, 10, 558-561.
43. Graff, A.; Sauer, M.; Gelder, P. V.; Meier, W. Virus-Assisted Loading of Polymer Nanocontainer. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 5064-5068.
44. Broz, P.; Benito, S. M.; Saw, C.; Burger, P.; Heider, H.; Pfisterer, M.; Marsch, S.; Meier, W.; Hunziker, P. Cell Targeting by a Generic Receptor-Targeted Polymer Nanocontainer Platform. J. Controlled Release 2005, 102, 475-488.
45. Ben-Haim, N.; Broz, P.; Marsch, S.; Meier, W.; Hunziker, P. Cell-Specific Integration of Artificial Organelles Based on Functionalized Polymer Vesicles. Nano Lett. 2008, 8, 1368-1373.